Author: Alistair Mukondiwa

Generics vs Brand Biologics: How Much Do They Really Cost?

Biosimilars cut the cost of biologic drugs by over 50% on average, yet most patients still pay full price. Learn why the savings are real, why adoption is slow, and how you can access lower-cost alternatives.

26.02.26
Alistair Mukondiwa
0

RSV Infections: Risks for Infants, Older Adults, and How to Prevent Them

RSV is the leading cause of hospitalization in infants and a major threat to older adults. Learn the real risks, how it spreads, and the new vaccines and preventions that are changing outcomes.

24.02.26
Alistair Mukondiwa
2

Using Copay Cards Safely: Access Without Compromising Care

Copay cards help patients afford expensive medications-but hidden insurer policies like accumulator programs can leave you owing thousands when the card runs out. Learn how to protect your treatment and avoid dangerous financial surprises.

17.02.26
Alistair Mukondiwa
8

How to Appeal Insurance Denials for Brand-Name Medications

Learn how to successfully appeal insurance denials for brand-name medications with step-by-step guidance, real-world examples, and key documentation tips to get your prescription covered.

13.02.26
Alistair Mukondiwa
10

Generic Drug Quality Standards: FDA Requirements and Testing

Generic drugs must meet the same strict quality, safety, and effectiveness standards as brand-name drugs. The FDA ensures this through rigorous testing, manufacturing oversight, and bioequivalence requirements - making generics safe, reliable, and affordable.

10.02.26
Alistair Mukondiwa
13

Supply Chain Problems: Distribution Risks for Generic Drugs

Generic drug shortages are at record levels due to thin profit margins, overreliance on overseas manufacturing, and lack of supply chain resilience. This affects patient care across the U.S., especially for critical injectables and older medications.

7.02.26
Alistair Mukondiwa
8

Global Generic Drug Policies: How Countries Balance Affordability and Quality

Exploring global generic drug policies, from U.S. savings to China's price cuts. Learn about challenges, expert views, and future trends in pharmaceutical affordability.

5.02.26
Alistair Mukondiwa
9

How the US Government Regulates Generic Drug Prices

The US government regulates generic drug prices through programs like Medicaid rebates and Medicare Part D. Learn how these policies affect costs, patient affordability, and recent changes under the Inflation Reduction Act. Key mechanisms include the Medicaid Drug Rebate Program and the 340B initiative, which lower prices for vulnerable populations. Current debates focus on price volatility and international comparisons. Discover how these regulations impact everyday healthcare costs.

4.02.26
Alistair Mukondiwa
12

Travel Medication Plans: Time Zones, Storage, and Side Effect Prevention

Traveling across time zones can disrupt your medication schedule, leading to side effects or treatment failure. Learn how to adjust dosing, store meds safely, avoid legal issues, and prevent errors with expert-backed tips for all types of prescriptions.

3.02.26
Alistair Mukondiwa
9

How to Prevent SGLT2 Inhibitor Genital Infections with Hygiene, Hydration, and Timing

SGLT2 inhibitors help manage diabetes and protect your heart and kidneys-but they can cause genital infections. Learn how simple hygiene, hydration, and timing can cut your risk by up to 40% without stopping your medication.

2.02.26
Alistair Mukondiwa
0

Generic Drug Quality Standards: FDA Requirements and Testing
10 Feb 2026
Antihistamine Tolerance: Does Long‑Term Use Reduce Effectiveness?
25 Oct 2025
International ICH Guidelines: How Global Harmonization Improves Medication Safety
31 Dec 2025
Aspirin with Other Blood Thinners: What You Need to Know About Bleeding Risks
8 Jan 2026
How to Choose OTC Eye Drops for Allergies, Dryness, and Redness
2 Dec 2025